248
Views
5
CrossRef citations to date
0
Altmetric
Original Article

A Comparison of Intravitreal Bevacizumab and Steroid Activity in an Experimental Uveitis Model

, , &
Pages 1261-1268 | Received 13 Aug 2014, Accepted 27 Nov 2014, Published online: 29 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Libei Zhao, Xuetao Huang, Manqiang Peng, Qian Tan, Wenxiang Lin, Muhammad Ahmad Khan, Qiongyan Tang & Ding Lin. (2020) Sub-Tenon Sustained Controllable Delivery of Dexamethasone for Treating Severe Acute Experimental Uveitis. Ocular Immunology and Inflammation 28:6, pages 984-993.
Read now
Hyemin Seong, Jinhyun Ryu, Woong-Sun Yoo, Seong Jae Kim, Yong‑Seop Han, Jong Moon Park, Sang Soo Kang & Seong Wook Seo. (2017) Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3. Current Eye Research 42:12, pages 1650-1658.
Read now

Articles from other publishers (3)

Mayara Rodrigues Brandão de PaivaDaniel Vítor de Vasconcelos-SantosMárcio Matos CoelhoRenes Resende MachadoNorberto Peporine LopesArmando Silva-CunhaSilvia Ligório Fialho. (2021) Licarin A as a Novel Drug for Inflammatory Eye Diseases. Journal of Ocular Pharmacology and Therapeutics 37:5, pages 290-300.
Crossref
Brenda Fernanda Moreira Castro, Lorena Carla Vieira, Daniel Vitor Vasconcelos-Santos, Sarah Pereira de Freitas Cenachi, Oliver Araújo Lacerda Cotta, Maria Carolina Andrade Guerra, Mayara Rodrigues Brandão Paiva, Luciana Maria Silva, Armando Silva-Cunha & Sílvia Ligório Fialho. (2020) Intravitreal thalidomide ameliorates inflammation in a model of experimental uveitis induced by BCG. International Immunopharmacology 81, pages 106129.
Crossref
Gokhan Ozge, Murat Kucukevcilioglu & Mehmet Talay Koylu. (2016) Comment on: “Autoimmune uveitis: clinical, pathogenetic, and therapeutic features”. Clinical and Experimental Medicine 16:2, pages 137-138.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.